LSU Royalty and Other Pre-Existing Third Party Royalties Sample Clauses

LSU Royalty and Other Pre-Existing Third Party Royalties. The royalty -------------------------------------------------------- payable to Louisiana State University under LSU Patents for sales of Collaboration Products in the Profit/Loss Sharing Territory shall be an Allowable Expense, and ERGO and ORTHO shall each be responsible for 50% of such royalty. The royalty payable to Louisiana State University under LSU Patents for sales of Collaboration Products in any former Profit/Loss Sharing Territory shall be borne equally by the parties, and ORTHO, in addition to any other royalties payable to ERGO pursuant to the terms of this Agreement in a former Profit/Loss Sharing Territory ORTHO shall pay to ERGO [*] of the royalty amount due LSU under the LSU Agreement. ERGO shall be responsible for payment of royalties to LSU and shall provide written documentation to ORTHO of such payment of royalties for purposes of calculating Operating Profits and Losses by ORTHO and for the purposes of verifying the correctness of ORTHO's payments with respect to the former Profit/Loss Sharing Territory. ORTHO shall not be responsible in the Profit/Loss Sharing Territory or the Royalty Bearing Territory for any portion of any royalty owed to any Third Party pursuant to an agreement between ERGO and such Third Party that existed prior to the Effective Date, other than as set forth above with respect to royalties in the Profit/Loss Sharing Territory due to LSU.
AutoNDA by SimpleDocs

Related to LSU Royalty and Other Pre-Existing Third Party Royalties

  • Third Party Royalties Each party shall be responsible for all of its own costs of commercializing Products or licensing Intellectual Property Rights, including any payments to Third Parties for work done by such Third Parties or for licenses necessary for the manufacture, sale, or use of Products by a party or its Affiliates or sublicensees.

  • Sublicense Fees Licensee will pay Sublicense Fees indicated in Section 3.1(e) of the Patent & Technology License Agreement on or before the Quarterly Payment Deadline for the Contract Quarter.

  • Know-How Royalty Notwithstanding the provisions of Section 5.4.1(a), in countries where the sale of Product by Merck or its Related Parties would not infringe a Valid Patent Claim, Merck shall pay royalty rates that shall be set at [***] of the applicable royalty rate determined according to Section 5.4.1(a). Such royalties shall be calculated after first calculating royalties under Section 5.4.1(a).

  • Earned Royalties Subject to of Article 7 hereof, Licensee shall pay to Licensor for the rights granted hereunder a sum equal to one and [*****] of the Net Invoice Value of Trademarked Products Sold by Licensee (the "Royalties"). The Royalties shall be remitted in accordance with Section 7.4 of this Agreement. 6.2

  • Sublicense Income Company shall pay Medical School {***} of all Sublicense Income. Such amounts shall be due and payable within sixty (60) days after Company receives the relevant payment from the Sublicensee.

  • Royalties 8.1 In consideration of the license herein granted, LICENSEE shall pay royalties to LICENSOR as follows:

  • Earned Royalty In addition, Alnylam will pay Stanford earned royalties on Net Sales as follows:

  • Royalties on Net Sales Novo will pay to Neose royalties as a percentage of annual Net Sales of each New Product during the Term at the applicable rates set forth in this Section 4.1 and in accordance with this Section 4:

  • License Fees If so provided in the Prospectus, the Depositor may enter into a Licensing Agreement (the "Agreement") with a licensor (the "Licensor") described in the Prospectus in which the Trust(s), as consideration for the licenses granted by the Licensor for the right to use its trademarks and trade names, intellectual property rights or for the use of databases and research owned by the Licensor, will pay a fee set forth in the Agreement to the applicable Licensor or the Depositor to reimburse the Depositor for payment of the expenses. If the Agreement provides for an annual license fee computed in whole or part by reference to the average daily net asset value of the Trust assets, for purpose of calculating the accrual of estimated expenses such annual fee shall accrue at a daily rate and the Trustee is authorized to compute an estimated license fee payment (i) until the Depositor has informed the Trustee that there will be no further deposits of additional Securities, by reference to an estimate of the average daily net asset value of the Trust assets which the Depositor shall provide the Trustee, (ii) thereafter and during the calendar quarter in which the last business day of the period described in clause (i) occurs, by reference to the net asset value of the Trust assets as of such last business day, and (iii) during each subsequent calendar quarter, by reference to the net asset value of the Trust assets as of the last business day of the preceding calendar quarter. The Trustee shall adjust the net asset value (Trust Fund Evaluation) as of the dates specified in the preceding sentence to account for any variation between accrual of estimated license fee and the license fee payable pursuant to the Agreement, but such adjustment shall not affect calculations made prior thereto and no adjustment shall be made in respect thereof.

  • Fees and Royalties The parties hereto understand that the fees and royalties payable by LICENSEE to UNIVERSITY under this Agreement are partial consideration for the license granted herein to LICENSEE under Patent Rights. LICENSEE shall pay UNIVERSITY:

Time is Money Join Law Insider Premium to draft better contracts faster.